At a glance
- Originator Abbott Laboratories
- Class Antipsychotics
- Mechanism of Action Dopamine D1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psychotic disorders
Most Recent Events
- 14 Dec 1994 Discontinued-Preclinical for Psychotic disorders in USA (Unknown route)